The pharmacology of vesamicol: an inhibitor of the vesicular acetylcholine transporter
- PMID: 1487110
- DOI: 10.1016/0306-3623(92)90280-w
The pharmacology of vesamicol: an inhibitor of the vesicular acetylcholine transporter
Abstract
1. Vesamicol (2-[4-phenylpiperidino] cyclohexanol) inhibits the transport of acetylcholine into synaptic vesicles in cholinergic nerve terminals. 2. Recent pharmacological studies of the effects of vesamicol on skeletal neuromuscular transmission have revealed a pattern of activity for the compound consistent with the neurochemical observation of the mechanism of action of the compound. 3. Pharmacological manipulation of vesicular acetylcholine transport has been used to investigate the recycling and mobilization of synaptic vesicles within cholinergic nerve terminals. 4. In addition to its effects on vesicular acetylcholine transport, vesamicol also possesses some sodium channel and alpha-adrenoceptor blocking activity. 5. Vesamicol clearly represents a unique tool for investigating presynaptic mechanisms in cholinergic nerve terminals.
Similar articles
-
Empty synaptic vesicles recycle and undergo exocytosis at vesamicol-treated motor nerve terminals.J Neurophysiol. 1999 Jun;81(6):2696-700. doi: 10.1152/jn.1999.81.6.2696. J Neurophysiol. 1999. PMID: 10368389
-
Analysis of uptake and release of newly synthesized acetylcholine in PC12 cells overexpressing the rat vesicular acetylcholine transporter (VAChT).Brain Res Mol Brain Res. 2002 Apr 30;100(1-2):21-30. doi: 10.1016/s0169-328x(02)00141-9. Brain Res Mol Brain Res. 2002. PMID: 12008018
-
Acetylcholine transporter--vesamicol receptor pharmacology and structure.Prog Brain Res. 1993;98:175-81. doi: 10.1016/s0079-6123(08)62396-1. Prog Brain Res. 1993. PMID: 8248506 Review. No abstract available.
-
Piperazine analog of vesamicol: in vitro and in vivo characterization for vesicular acetylcholine transporter.Synapse. 2000 Oct;38(1):27-37. doi: 10.1002/1098-2396(200010)38:1<27::AID-SYN4>3.0.CO;2-1. Synapse. 2000. PMID: 10941138
-
The cholinergic gene locus.J Neurochem. 1998 Jun;70(6):2227-40. doi: 10.1046/j.1471-4159.1998.70062227.x. J Neurochem. 1998. PMID: 9603187 Review.
Cited by
-
Memantine has a nicotinic neuroprotective pathway in acute hippocampal slices after an NMDA insult.Toxicol In Vitro. 2022 Oct;84:105453. doi: 10.1016/j.tiv.2022.105453. Epub 2022 Aug 6. Toxicol In Vitro. 2022. PMID: 35944748 Free PMC article.
-
Calcitonin gene-related peptide acts presynaptically to increase quantal size and output at frog neuromuscular junctions.J Physiol. 1998 Mar 15;507 ( Pt 3)(Pt 3):689-95. doi: 10.1111/j.1469-7793.1998.689bs.x. J Physiol. 1998. PMID: 9508830 Free PMC article.
-
Quantal release of acetylcholine in mice with reduced levels of the vesicular acetylcholine transporter.J Neurochem. 2010 May;113(4):943-51. doi: 10.1111/j.1471-4159.2010.06657.x. Epub 2010 Feb 25. J Neurochem. 2010. PMID: 20202084 Free PMC article.
-
Cholinergic Depletion in Alzheimer's Disease Shown by [ (18) F]FEOBV Autoradiography.Int J Mol Imaging. 2013;2013:205045. doi: 10.1155/2013/205045. Epub 2013 Nov 10. Int J Mol Imaging. 2013. PMID: 24324884 Free PMC article.
-
TGF-beta2 alters the characteristics of the neuromuscular junction by regulating presynaptic quantal size.Proc Natl Acad Sci U S A. 2010 Jul 27;107(30):13515-9. doi: 10.1073/pnas.1001695107. Epub 2010 Jul 12. Proc Natl Acad Sci U S A. 2010. PMID: 20624974 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources